American depository receipts of European stocks were trading 0.69% higher at 134.42 on the Bank of New York Mellon Europe ADR Index on Monday.
In continental Europe, the gainers were led by cell therapy company TiGenix ( TIG ), and bank Banco Bilbao Vizcaya Argentaria ( BBVA ), which rose 5.6% and 2.2% respectively. They were followed by bank Banco Santander ( SAN ), and financial services firm Credit Suisse ( CS ), which were up 2.2% and 2% each.
The decliners in continental Europe were led by digital advertising firm Criteo ( CRTO ), and biopharmaceutical company Nabriva Therapeutics (NBRV), which lost 3% and 1.9% respectively. They were followed by biopharmaceutical company DBV Technologies S.A. (DBVT), and semiconductor company Sequans Communications (SQNS), which dropped 1.4% and 1.2% each.
In the U.K. and Ireland, the gainers were led by biopharmaceutical company Akari Therapeutics (AKTX), and specialty pharmaceutical company Midatech Pharma (MTP), which climbed 6.6% and 2.8% each. Royal Bank of Scotland (RBS), and Barclays Bank (BCS) rose 2.7% and 2.2% respectively.
The decliners in the U.K. and Ireland were led by Adaptimmune Therapeutics (ADAP), and gold mining company Randgold Resources (GOLD), which dropped 2.4% and 1.3% respectively. They were followed by biopharmaceutical company GW Pharmaceuticals (GWPH), and education company Pearson (PSO), which lost 1.2% and 0.2% each.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
